Expansion Opportunity Second location opening in Rockville, MD signals regional growth and increased patient access. Target outreach to expand referral networks with nearby primary care providers, pain clinics, and specialty practices in DC, Maryland, and Northern Virginia.

Interventional Focus Combination of ketamine therapy, ketamine-assisted psychotherapy, TMS, and stellate ganglion blocks positions WIP at the intersection of pharmacologic and interventional treatments. Cross-sell integrated care options to patients with chronic migraines, treatment-resistant depression, and anxiety disorders seeking multi-modal approaches.

Clinical Collaboration Board-certified psychiatry leadership and collaborative care with therapists enable scalable referral pipelines. Develop partnerships with referring clinicians and outpatient clinics to coordinate continuous care and expand patient flow for interventional modalities.

Digital & Outreach Existing tech stack and online presence can be leveraged for patient education and lead generation. Implement targeted campaigns around ketamine therapy and KAP for migraines and mood disorders, and optimize SEO to attract regionally seeking interventional psychiatry services.

Financial Tailwinds Moderate revenue range indicates growth potential with expanded services and locations. Explore strategic partnerships, insurance acceptance strategies, and bundled care programs to increase case volume and improve payer mix in the expanded DC–MD–VA footprint.